Novartis - Conférence R&D

November 18, 2003 23:30 ET | Source: Novartis Pharma AG Novartis Pharma AG

Novartis - Conférence R&D

Bâle, 19 novembre 2003

Aujourd'hui Novartis consacrera sa journée annuelle à la recherche et au développement avec le « R&D Day » à New York. Elle y présentera son pipeline de produits pharmaceutiques aux medias et aux analystes.

Please find press conference logistics under the following link:

Attachments

Novartis Release...

Recommended Reading

March 29, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta...
Read More
March 27, 2026 02:00 ET | Source: Novartis Pharma AG

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation

- Proposed acquisition strengthens Novartis immunology strategy in food allergy and other IgE-driven diseases - Lead asset Exl-111 builds on proven IgE biology with a differentiated mechanism...
Read More